Page last updated: 2024-08-21

isoxazoles and Psoriasis Arthropathica

isoxazoles has been researched along with Psoriasis Arthropathica in 40 studies

Research

Studies (40)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's25 (62.50)29.6817
2010's15 (37.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahern, MJ; Barbara, JA; Russo, PA; Shanahan, EM; Smith, MD; Wiese, MD1
Orr, C; Veale, DJ1
Batat, E; Bitterman, H; Cohen, AD; Cohen, S; Comanesther, D; Feldhamer, I; Greenberg-Dotan, S; Shalom, G; Zisman, D1
Dejaco, C; Duftner, C; Ficjan, A; Graninger, WB; Gretler, J; Gutierrez, M; Hermann, J; Husic, R; Lackner, A1
Al-Mossawi, MH; Bowness, P; Brennan, PE; de Wit, J; Fedorov, O; Hammitzsch, A; Hay, DA; Knapp, S; Martinez, FO; Müller, S; O'Mahony, A; Tallant, C; Vecellio, M; Wells, C; Wordsworth, P1
Avcin, T; Calonje, E; Luzar, B; Vesel, T1
Beukelman, T; Cassell, S; Curtis, JR; Greenberg, JD; Kavanaugh, A; Kremer, JM; Onofrei, A; Reed, G; Strand, V1
Abdelmoula, LC; Ben M'Barek, R; Chaabouni, L; Tekaya, R; Testouri, N; Yahia, CB; Zouari, R1
Cantagrel, A; Claudepierre, P; Combe, B; Dernis, E; Flipo, RM; Gaudin, P; Goupille, P; Lavie, F; Le Loët, X; Maillefert, JF; Paul, C; Salliot, C; Saraux, A; Schaeverbeke, T; Tebib, J; Wendling, D1
Alivernini, S; Ferraccioli, G; Mazzotta, D; Zoli, A1
Callado, MR; Vieira, FJ; Vieira, WP1
Huang, F; Li, XF; Zhang, GL; Zhang, JL1
Hutchinson, DG; Lee, MA1
Matuszewska, A; Misterska-Skóra, M; Wiland, P1
Boulinguez, S; Goupille, P; Passeron, T1
Anić, B; Babić-Naglić, D; Grazio, S; Martinavić Kaliterna, D; Novak, S1
Jagoda, JS; Rajapakse, CN1
Lubrano, E; Scarpa, R1
Behrens, F; Burkhardt, H; Finkenwirth, C; Pavelka, K; Šipek-Dolnicar, A; Štolfa, J; Thaçi, D1
Anastasilakis, AD; Kapetanos, GA; Sakellariou, GT; Sayegh, FE1
Cuchacovich, M; Soto, L1
Fantini, F1
Behrens, F; Falk, FG; Gladman, D; Jones, P; Kaltwasser, JP; Mease, P; Nash, P; Rosen, CF; Wollenhaupt, J1
Gladman, DD1
Garg, G; Thami, GP1
Braun, J; Haibel, H; Rudwaleit, M; Sieper, J1
Chandler, D; Griffiths, CE; Helliwell, P; Kyle, S; Lewis, J; McHugh, N; McInnes, I; Oliver, S; Symmons, D1
Schmitt, J; Wozel, G1
Goupille, P1
Behrens, F; Falk, F; Kaltwasser, JP; Nash, P; Thaçi, D1
Braun, J; Sieper, J1
Choy, EH; Ravindran, V; Scott, DL1
McHugh, NJ; Soriano, ER1
Kaltwasser, JP1
Denisov, LN; Godzenko, AA; Korotaeva, TV; Korsakova, IuL; Pchelintseva, AO; Stanislav, ML1
Delaporte, E; Delesalle, F; Gautier, S; Gros, C1
Bagot, M; Claudepierre, P1
Bodur, H; Ergül, G; Eser, F; Seçkin, S; Seçkin, U1
Beckmann, I; Hummel, KM; Mössner, R; Neumann, C; Reich, K1

Reviews

9 review(s) available for isoxazoles and Psoriasis Arthropathica

ArticleYear
[Update in treatment of psoriatic arthritis].
    La Tunisie medicale, 2008, Volume: 86, Issue:12

    Topics: Adalimumab; Alefacept; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Psoriatic; Dermatologic Agents; Humans; Isoxazoles; Leflunomide; Recombinant Fusion Proteins; Tumor Necrosis Factor-alpha

2008
Psoriatic arthritis: treatment strategies using anti-inflammatory drugs and classical DMARDs.
    Reumatismo, 2012, Jun-05, Volume: 64, Issue:2

    Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Psoriatic; Clinical Trials as Topic; Cyclosporine; Evidence-Based Medicine; Humans; Isoxazoles; Joints; Leflunomide; Methotrexate; Multicenter Studies as Topic; Nails; Skin; Sulfasalazine

2012
[New drugs and treatment strategies for rheumatoid arthritis].
    Recenti progressi in medicina, 2003, Volume: 94, Issue:9

    Topics: Adalimumab; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Juvenile; Arthritis, Psoriatic; Arthritis, Rheumatoid; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Etanercept; Follow-Up Studies; Humans; Immunoglobulin G; Immunologic Factors; Infliximab; Interleukin 1 Receptor Antagonist Protein; Interleukin-1; Isoxazoles; Leflunomide; Middle Aged; Multicenter Studies as Topic; Placebos; Randomized Controlled Trials as Topic; Receptors, Interleukin-1; Receptors, Tumor Necrosis Factor; Sialoglycoproteins; Time Factors; Tumor Necrosis Factor-alpha

2003
Psoriatic arthritis.
    Dermatologic therapy, 2004, Volume: 17, Issue:5

    Topics: Adalimumab; Alefacept; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimalarials; Arthritis, Psoriatic; Azathioprine; Cyclosporine; Etanercept; Gold Sodium Thiomalate; Humans; Immunoglobulin G; Infliximab; Isoxazoles; Leflunomide; Receptors, Tumor Necrosis Factor; Receptors, Tumor Necrosis Factor, Type I; Recombinant Fusion Proteins; Sulfasalazine; Tumor Necrosis Factor Decoy Receptors

2004
Guideline for anti-TNF-alpha therapy in psoriatic arthritis.
    Rheumatology (Oxford, England), 2005, Volume: 44, Issue:3

    Topics: Algorithms; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Psoriatic; Etanercept; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Isoxazoles; Leflunomide; Receptors, Tumor Necrosis Factor; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha

2005
Psoriatic arthritis.
    Joint bone spine, 2005, Volume: 72, Issue:6

    Topics: Adalimumab; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Psoriatic; Etanercept; Humans; Immunoglobulin G; Immunologic Factors; Infliximab; Isoxazoles; Leflunomide; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha

2005
A systematic review and meta-analysis of efficacy and toxicity of disease modifying anti-rheumatic drugs and biological agents for psoriatic arthritis.
    Annals of the rheumatic diseases, 2008, Volume: 67, Issue:6

    Topics: Alefacept; Antirheumatic Agents; Arthritis, Psoriatic; Biological Products; Humans; Isoxazoles; Leflunomide; Randomized Controlled Trials as Topic; Recombinant Fusion Proteins; Risk Assessment; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor-alpha

2008
Conventional therapy of psoriatic arthritis: evidence-based review.
    Reumatismo, 2007, Volume: 59 Suppl 1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Psoriatic; Cyclosporine; Drug Therapy, Combination; Evidence-Based Medicine; Glucocorticoids; Humans; Isoxazoles; Leflunomide; Methotrexate; Mycophenolic Acid; Sulfasalazine; Treatment Outcome

2007
Leflunomide in psoriatic arthritis.
    Autoimmunity reviews, 2007, Volume: 6, Issue:8

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Psoriatic; Humans; Isoxazoles; Leflunomide

2007

Trials

6 trial(s) available for isoxazoles and Psoriasis Arthropathica

ArticleYear
[A clinical study of leflunomide and methotrexate therapy in psoriatic arthritis].
    Zhonghua nei ke za zhi, 2009, Volume: 48, Issue:7

    Topics: Adult; Arthritis, Psoriatic; Drug Therapy, Combination; Female; Humans; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Treatment Outcome

2009
Efficacy and safety of leflunomide in the treatment of psoriatic arthritis and psoriasis: a multinational, double-blind, randomized, placebo-controlled clinical trial.
    Arthritis and rheumatism, 2004, Volume: 50, Issue:6

    Topics: Adult; Aged; Arthritis, Psoriatic; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Middle Aged; Placebos; Quality of Life; Treatment Outcome

2004
Leflunomide in psoriasis and psoriatic arthritis: a preliminary study.
    Archives of dermatology, 2004, Volume: 140, Issue:10

    Topics: Adjuvants, Immunologic; Adult; Aged; Arthritis, Psoriatic; Female; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Psoriasis; Treatment Outcome

2004
Six months open label trial of leflunomide in active ankylosing spondylitis.
    Annals of the rheumatic diseases, 2005, Volume: 64, Issue:1

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis; Arthritis, Psoriatic; Female; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Patient Dropouts; Severity of Illness Index; Spondylitis, Ankylosing; Treatment Outcome

2005
Leflunomide improves psoriasis in patients with psoriatic arthritis: an in-depth analysis of data from the TOPAS study.
    Dermatology (Basel, Switzerland), 2006, Volume: 212, Issue:3

    Topics: Adjuvants, Immunologic; Administration, Oral; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Psoriatic; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Middle Aged; Psoriasis; Quality of Life; Skin

2006
[Results of leflunomide treatment of psoriatic arthritis].
    Terapevticheskii arkhiv, 2007, Volume: 79, Issue:8

    Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Arthralgia; Arthritis, Psoriatic; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Middle Aged; Pain Measurement; Quality of Life; Retrospective Studies; Surveys and Questionnaires; Time Factors; Treatment Outcome

2007

Other Studies

25 other study(ies) available for isoxazoles and Psoriasis Arthropathica

ArticleYear
Leflunomide for inflammatory arthritis in end-stage renal disease on peritoneal dialysis: a pharmacokinetic and pharmacogenetic study.
    The Annals of pharmacotherapy, 2013, Volume: 47, Issue:3

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Psoriatic; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cytochrome P-450 CYP2C19; Humans; Isoxazoles; Kidney Failure, Chronic; Leflunomide; Male; Neoplasm Proteins; Peritoneal Dialysis; Polymorphism, Single Nucleotide

2013
Is there a need for new agents with novel mechanisms of action in psoriatic arthritis?
    Annals of the rheumatic diseases, 2014, Volume: 73, Issue:6

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; Arthritis, Psoriatic; Humans; Interleukin-12; Interleukin-17; Interleukin-23; Isoxazoles; Leflunomide; Methotrexate; Signal Transduction; Tumor Necrosis Factor-alpha; Ustekinumab

2014
Psoriatic arthritis treatment and the risk of herpes zoster.
    Annals of the rheumatic diseases, 2016, Volume: 75, Issue:1

    Topics: Adalimumab; Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Azathioprine; Cyclosporine; Drug Combinations; Drug Therapy, Combination; Etanercept; Female; Glucosamine; Herpes Zoster; Humans; Hydroxychloroquine; Incidence; Infliximab; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Retrospective Studies; Sulfasalazine; Tumor Necrosis Factor-alpha

2016
Ultrasound composite scores for the assessment of inflammatory and structural pathologies in Psoriatic Arthritis (PsASon-Score).
    Arthritis research & therapy, 2014, Oct-31, Volume: 16, Issue:5

    Topics: Adult; Antirheumatic Agents; Arthritis, Psoriatic; Bone and Bones; Feasibility Studies; Female; Follow-Up Studies; Humans; Inflammation; Isoxazoles; Joints; Leflunomide; Male; Methotrexate; Middle Aged; Outcome Assessment, Health Care; Prospective Studies; Reproducibility of Results; Severity of Illness Index; Sulfasalazine; Surveys and Questionnaires; Synovial Membrane; Tendons; Time Factors; Ultrasonography, Doppler

2014
CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses.
    Proceedings of the National Academy of Sciences of the United States of America, 2015, Aug-25, Volume: 112, Issue:34

    Topics: Adult; Aged; Arthritis, Psoriatic; Azepines; Benzimidazoles; Calorimetry; CD4-Positive T-Lymphocytes; Cells, Cultured; Crystallography, X-Ray; Drug Evaluation, Preclinical; Female; Gene Expression Regulation; Humans; Immunosuppressive Agents; Interleukin-17; Isoxazoles; Kinetics; Male; Middle Aged; Models, Molecular; Molecular Structure; p300-CBP Transcription Factors; Protein Conformation; Protein Structure, Tertiary; Recombinant Proteins; Spondylitis, Ankylosing; Structure-Activity Relationship; Th17 Cells; Triazoles

2015
Syringotropic hypersensitivity reaction associated with infliximab and leflunomide combination therapy in a child with psoriatic arthritis.
    Journal of cutaneous pathology, 2009, Volume: 36, Issue:9

    Topics: Adolescent; Anti-Inflammatory Agents; Antibodies, Monoclonal; Arthritis, Psoriatic; Drug Hypersensitivity; Drug Therapy, Combination; Humans; Infliximab; Isoxazoles; Leflunomide; Male

2009
Elevated liver enzyme tests among patients with rheumatoid arthritis or psoriatic arthritis treated with methotrexate and/or leflunomide.
    Annals of the rheumatic diseases, 2010, Volume: 69, Issue:1

    Topics: Adolescent; Adult; Aged; Alanine Transaminase; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Aspartate Aminotransferases; Biomarkers; Chemical and Drug Induced Liver Injury; Clinical Enzyme Tests; Cohort Studies; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Young Adult

2010
Pharmacological treatment (biotherapy excluded) of peripheral psoriatic arthritis: development of recommendations for clinical practice based on data from the literature and experts opinion.
    Joint bone spine, 2009, Volume: 76, Issue:5

    Topics: Advisory Committees; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis, Psoriatic; Azathioprine; Evidence-Based Medicine; Expert Testimony; Follow-Up Studies; Glucocorticoids; Hospitals, Teaching; Humans; Isoxazoles; Joints; Leflunomide; Placebos; Practice Guidelines as Topic; Randomized Controlled Trials as Topic

2009
Leflunomide treatment in elderly patients with rheumatoid or psoriatic arthritis: retrospective analysis of safety and adherence to treatment.
    Drugs & aging, 2009, Volume: 26, Issue:5

    Topics: Adult; Age Factors; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Female; Follow-Up Studies; Humans; Isoxazoles; Italy; Leflunomide; Male; Medication Adherence; Middle Aged; Retrospective Studies; Severity of Illness Index; Survival Rate; Treatment Outcome

2009
Abatacept as an option therapy in difficult to treat psoriatic arthritis.
    Rheumatology international, 2010, Volume: 30, Issue:6

    Topics: Abatacept; Arthritis, Psoriatic; Drug Administration Schedule; Drug Resistance; Female; Hepatitis; Humans; Immunoconjugates; Immunosuppressive Agents; Isoniazid; Isoxazoles; Joints; Leflunomide; Leg; Methotrexate; Middle Aged; Nucleic Acid Synthesis Inhibitors; Skin; Treatment Outcome; Tumor Necrosis Factor-alpha

2010
HRCT-proven leflunomide pneumonitis in a patient with psoriatic arthritis and normal lung function tests and chest radiography.
    Rheumatology (Oxford, England), 2010, Volume: 49, Issue:6

    Topics: Antirheumatic Agents; Arthritis, Psoriatic; Female; Humans; Isoxazoles; Leflunomide; Lung Diseases, Interstitial; Middle Aged; Radiographic Image Enhancement; Respiratory Function Tests; Tomography, X-Ray Computed

2010
[Active psoriatic arthritis during pregnancy: challenges and limitations of pharmacotherapy].
    Annales Academiae Medicae Stetinensis, 2010, Volume: 56 Suppl 1

    Topics: Adult; Antirheumatic Agents; Arthritis, Psoriatic; Contraindications; Cyclosporine; Female; Humans; Isoxazoles; Leflunomide; Methotrexate; Prednisolone; Prednisone; Pregnancy; Pregnancy Complications; Sulfasalazine

2010
[Recommendations on the management of psoriatic arthritis].
    Annales de dermatologie et de venereologie, 2011, Volume: 138, Issue:6 Suppl 1

    Topics: Analgesics; Antirheumatic Agents; Arthritis, Psoriatic; Glucocorticoids; Humans; Immunosuppressive Agents; Injections, Intra-Articular; Isoxazoles; Leflunomide; Methotrexate; Sulfasalazine; Tumor Necrosis Factor-alpha

2011
[Treatment of rheumatoid and psoriatic arthritis--review of leflunomide].
    Reumatizam, 2010, Volume: 57, Issue:2

    Topics: Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Humans; Isoxazoles; Leflunomide

2010
Leflunomide in clinical practice. A retrospective observational study on use of leflunomide in New Zealand.
    International journal of rheumatic diseases, 2011, Volume: 14, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antirheumatic Agents; Arthritis, Psoriatic; Arthritis, Rheumatoid; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Isoxazoles; Kaplan-Meier Estimate; Leflunomide; Male; Middle Aged; New Zealand; Retrospective Studies; Young Adult

2011
Leflunomide in psoriatic arthritis: results from a large European prospective observational study.
    Arthritis care & research, 2013, Volume: 65, Issue:3

    Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Arthritis, Psoriatic; Europe; Female; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Prospective Studies; Treatment Outcome; Young Adult

2013
Leflunomide addition in patients with articular manifestations of psoriatic arthritis resistant to methotrexate.
    Rheumatology international, 2013, Volume: 33, Issue:11

    Topics: Adult; Antirheumatic Agents; Arthritis, Psoriatic; Disease Progression; Drug Therapy, Combination; Female; Humans; Isoxazoles; Leflunomide; Male; Methotrexate; Middle Aged; Retreatment; Retrospective Studies; Severity of Illness Index; Treatment Outcome

2013
Leflunomide decreases joint erosions and induces reparative changes in a patient with psoriatic arthritis.
    Annals of the rheumatic diseases, 2002, Volume: 61, Issue:10

    Topics: Adult; Antirheumatic Agents; Arthritis, Psoriatic; Follow-Up Studies; Foot; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Radiography

2002
Leflunomide: new indication. In psoriatic rheumatism: too many risks, too little efficacy.
    Prescrire international, 2005, Volume: 14, Issue:78

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Psoriatic; Clinical Trials as Topic; Cost-Benefit Analysis; Drug Approval; France; Humans; Immunosuppressive Agents; Isoxazoles; Treatment Outcome

2005
[Psoriasis arthritis--long-term treatment of two patients with leflunomide].
    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2004, Volume: 2, Issue:9

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Arthritis, Psoriatic; Female; Humans; Isoxazoles; Leflunomide; Longitudinal Studies; Middle Aged; Pain Measurement; Quality of Life; Treatment Outcome

2004
[Spondylarthritides].
    Zeitschrift fur Rheumatologie, 2006, Volume: 65, Issue:7

    Topics: Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Child; Diagnostic Imaging; Etanercept; Female; HLA-B27 Antigen; Humans; Immunoglobulin G; Inflammatory Bowel Diseases; Infliximab; Isoxazoles; Leflunomide; Male; Methotrexate; Physical Therapy Modalities; Receptors, Tumor Necrosis Factor; Spine; Spondylarthritis; Spondylitis, Ankylosing; Sulfasalazine

2006
[Leflunomide-induced skin necrosis].
    Annales de dermatologie et de venereologie, 2008, Volume: 135, Issue:3

    Topics: Abdomen; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Psoriatic; Female; Follow-Up Studies; Humans; Isoxazoles; Leflunomide; Necrosis; Skin; Time Factors

2008
[Psoriatic arthritis].
    Annales de dermatologie et de venereologie, 2008, Volume: 135 Suppl 4

    Topics: Arthritis, Psoriatic; Cyclosporine; Diagnosis, Differential; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Psoriasis

2008
Coexistence of familial Mediterranean fever and psoriasis in a patient with seronegative spondyloarthropathy.
    Rheumatology international, 2008, Volume: 29, Issue:1

    Topics: Adult; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Psoriatic; Colchicine; Drug Therapy, Combination; Familial Mediterranean Fever; Gout Suppressants; Health Status; Humans; Immunosuppressive Agents; Infliximab; Isoxazoles; Leflunomide; Male; Severity of Illness Index; Spondylarthropathies; Treatment Outcome

2008
Treatment of severe psoriasis and psoriatic arthritis with leflunomide.
    The British journal of dermatology, 2002, Volume: 146, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Psoriatic; Female; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Psoriasis

2002